The scientific evidence brought by the medical literature in this systematic review confirms that NMO is an associated HLA disease, thus classified because it occurs more frequently in individuals expressing certain DRB1 or DPB1 alleles. This evidence concerns the gene HLA-DPB1 and neuromyelitis optica.